You just read:

Regeneron and Sanofi to Present Data from Phase 3 Praluent® (alirocumab) Injection Clinical Trials at AHA Scientific Sessions 2016

News provided by

Regeneron Pharmaceuticals, Inc.

11 Nov, 2016, 09:00 ET